Trillium Therapeutics logo Candriam Luxembourg S.C.A. lowered its stake in Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) by 14.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC ...
more»